Effect of Salt Substitution on Cardiovascular Events and Death
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Salt substitutes with reduced sodium levels and increased potassium levels have been shown to lower blood pressure, but their effects on cardiovascular and safety outcomes are uncertain. METHODS: We conducted an open-label, cluster-randomized trial involving persons from 600 villages in rural China. The participants had a history of stroke or were 60 years of age or older and had high blood pressure. The villages were randomly assigned in a 1:1 ratio to the intervention group, in which the participants used a salt substitute (75% sodium chloride and 25% potassium chloride by mass), or to the control group, in which the participants continued to use regular salt (100% sodium chloride). The primary outcome was stroke, the secondary outcomes were major adverse cardiovascular events and death from any cause, and the safety outcome was clinical hyperkalemia. RESULTS: A total of 20,995 persons were enrolled in the trial. The mean age of the participants was 65.4 years, and 49.5% were female, 72.6% had a history of stroke, and 88.4% a history of hypertension. The mean duration of follow-up was 4.74 years. The rate of stroke was lower with the salt substitute than with regular salt (29.14 events vs. 33.65 events per 1000 person-years; rate ratio, 0.86; 95% confidence interval [CI], 0.77 to 0.96; P = 0.006), as were the rates of major cardiovascular events (49.09 events vs. 56.29 events per 1000 person-years; rate ratio, 0.87; 95% CI, 0.80 to 0.94; P<0.001) and death (39.28 events vs. 44.61 events per 1000 person-years; rate ratio, 0.88; 95% CI, 0.82 to 0.95; P<0.001). The rate of serious adverse events attributed to hyperkalemia was not significantly higher with the salt substitute than with regular salt (3.35 events vs. 3.30 events per 1000 person-years; rate ratio, 1.04; 95% CI, 0.80 to 1.37; P = 0.76). CONCLUSIONS: Among persons who had a history of stroke or were 60 years of age or older and had high blood pressure, the rates of stroke, major cardiovascular events, and death from any cause were lower with the salt substitute than with regular salt. (Funded by the National Health and Medical Research Council of Australia; SSaSS ClinicalTrials.gov number, NCT02092090.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, salt substitution with reduced sodium levels and increased potassium levels has been shown to reduce stroke, CVD, and overall mortality in patients with high CV risk.96”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Self-citationSacco, R. L., Kasner, S. E., Broderick, J. P., Caplan, L. R., Connors, J. J. (., Culebras, A., Elkind, M. S. V., George, M. G., Hamdan, A. D., Higashida, R. T., et al. (2013) · Stroke · doi:10.1161/str.0b013e318296aeca · Cited by 3,569
Effect of lower sodium intake on health: systematic review and meta-analyses
Aburto, N. J., Ziolkovska, A., Hooper, L., Elliott, P., Cappuccio, F. P., & Meerpohl, J. J. (2013) · BMJ · doi:10.1136/bmj.f1326 · Cited by 1,242
Self-citationSalt intakes around the world: implications for public health
Brown, I. J., Tzoulaki, I., Candeias, V., & Elliott, P. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyp139 · Cited by 1,173
Self-citationAburto, N. J., Hanson, S., Gutierrez, H., Hooper, L., Elliott, P., & Cappuccio, F. P. (2013) · BMJ · doi:10.1136/bmj.f1378 · Cited by 938
Self-citationSodium and Potassium in the Pathogenesis of Hypertension
Adrogué, H. J., & Madias, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmra064486 · Cited by 763
Huang, L., Trieu, K., Yoshimura, S., Neal, B., Woodward, M., Campbell, N. R. C., Li, Q., Lackland, D. T., Leung, A. A., Anderson, C. A. M., et al. (2020) · BMJ · doi:10.1136/bmj.m315 · Cited by 403
Self-citationCobb, L. K., Anderson, C. A. M., Elliott, P., Hu, F. B., Liu, K., Neaton, J. D., Whelton, P. K., Woodward, M., & Appel, L. J. (2014) · Circulation · doi:10.1161/cir.0000000000000015 · Cited by 300
Self-citationPotassium Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials
Filippini, T., Naska, A., Kasdagli, M., Torres, D., Lopes, C., Carvalho, C., Moreira, P., Malavolti, M., Orsini, N., Whelton, P. K., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015719 · Cited by 271
A Systematic Review of the Sources of Dietary Salt Around the World
Bhat, S., Marklund, M., Henry, M. E., Appel, L. J., Croft, K. D., Neal, B., & Wu, J. H. Y. (2020) · Advances in Nutrition · doi:10.1093/advances/nmz134 · Cited by 221
Self-citation
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
“253,255 A comparable decrease in the Na + /K + ratio was estimated to reduce CVD risk by about 30%.”
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
The path to healthy ageing in China: a Peking University–Lancet Commission
Chen, X., Giles, J., Yao, Y., Yip, W., Meng, Q., Berkman, L., Chen, H., Chen, X., Feng, J., Feng, Z., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01546-x · Cited by 968
Self-citationEpidemiology and risk of cardiovascular disease in populations with chronic kidney disease
Matsushita, K., Ballew, S. H., Wang, A. Y.-M., Kalyesubula, R., Schaeffner, E., & Agarwal, R. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00616-6 · Cited by 670
China stroke surveillance report 2021
Tu, W.-J., Wang, L.-D., on behalf of the Special Writing Group of China Stroke Surveillance Report, Yan, F., Peng, B., Hua, Y., Liu, M., Ji, X.-M., Ma, L., Shan, C.-L., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00463-x · Cited by 570
“The Salt Substitute and Stroke Study—a 5-year cluster randomized controlled trial, demonstrated that replacing regular salt with a reduced-sodium added-potassium salt substitute reduced the risks of stroke, major adverse cardiovascular events, and premature death among individuals with prior stroke or uncontrolled hig…”
BackgroundSelf-citationTreatment of hypertension: a review
Carey, R. M., Moran, A. E., & Whelton, P. K. (2022) · JAMA · doi:10.1001/jama.2022.19590 · Cited by 455
Report on cardiovascular health and diseases in China 2021: an updated summary
HU, S.-S. (2023) · Journal of Geriatric Cardiology · doi:10.26599/1671-5411.2023.06.001 · Cited by 428
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 360
Writing Committee Members*, Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., et al. (2025) · Hypertension · doi:10.1161/hyp.0000000000000249 · Cited by 310
24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk
Ma, Y., He, F. J., Sun, Q., Yuan, C., Kieneker, L. M., Curhan, G. C., MacGregor, G. A., Bakker, S. J. L., Campbell, N. R. C., Wang, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2109794 · Cited by 295
Charchar, F. J., Prestes, P. R., Mills, C., Ching, S. M., Neupane, D., Marques, F. Z., Sharman, J. E., Vogt, L., Burrell, L. M., Korostovtseva, L., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003563 · Cited by 297
“…potassium supplements and implementation of salt substitutes reduce BP with little effect on the risk of hyperkalaemia in a healthy population [142, a v z E ou m Unlike comprehensive interventions that require implementing and long-term adherence to dietary or behavioural change, the use of…”
Self-citationJones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.05.007 · Cited by 280
Palaniappan, L. P., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 242
Writing Committee Members*, Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001356 · Cited by 213
2024 Clinical practice guidelines for Hypertension in adults
Kobalava, Z. D., Konradi, A. O., Nedogoda, S. V., Shlyakhto, E. V., Arutyunov, G. P., Baranova, E. I., Barbarash, O. L., Bobkova, N. V., Boytsov, S. A., Bubnova, M. G., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6117 · Cited by 211
Hypertension management in patients with cardiovascular comorbidities
Lauder, L., Mahfoud, F., Azizi, M., Bhatt, D. L., Ewen, S., Kario, K., Parati, G., Rossignol, P., Schlaich, M. P., Teo, K. K., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac395 · Cited by 210
Abrahamowicz, A. A., Ebinger, J., Whelton, S. P., Commodore-Mensah, Y., & Yang, E. (2023) · Current Cardiology Reports · doi:10.1007/s11886-022-01826-x · Cited by 207
Liu, L., Li, Z., Zhou, H., Duan, W., Huo, X., Xu, W., Li, S., Nie, X., Liu, H., Liu, J., et al. (2023) · Stroke and Vascular Neurology · doi:10.1136/svn-2023-002998 · Cited by 199
Self-citationThe Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Zaman, S., Wasfy, J. H., Kapil, V., Ziaeian, B., Parsonage, W. A., Sriswasdi, S., Chico, T. J. A., Capodanno, D., Colleran, R., Sutton, N. R., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00055-8 · Cited by 203
Vegetarian and vegan diets: benefits and drawbacks
Wang, T., Masedunskas, A., Willett, W. C., & Fontana, L. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad436 · Cited by 197
“93 Other factors such as calorie restriction and weight loss, 30,54,106 lower dietary sodium and high potassium and magnesium intake, 53,55 and regular endurance exercise training 56 are important factors beyond fibre-rich plant food consumption.”
BackgroundThe impact of excessive salt intake on human health
Hunter, R. W., Dhaun, N., & Bailey, M. A. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00533-0 · Cited by 190
Western diets and chronic diseases
Adolph, T. E., & Tilg, H. (2024) · Nature Medicine · doi:10.1038/s41591-024-03165-6 · Cited by 191
“Indeed, epidemiologic, experimental and clinical evidence draws a clear picture: the Westernization of diet but also the consumption of alcohol 212 , drugs 213 , cigarette smoke 12,214 , salt intake 215 and a sedentary lifestyle 216,217 make people sick.”
Michel, M., Eldridge, A. L., Hartmann, C., Klassen, P., Ingram, J., & Meijer, G. W. (2024) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2024.104703 · Cited by 175
Hypertension in China: epidemiology and treatment initiatives
Wang, J.-G., Zhang, W., Li, Y., & Liu, L. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00829-z · Cited by 176
Self-citationChinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)
Wang, J. (2025) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2025.01.008 · Cited by 196
Schutte, A. E., Jafar, T. H., Poulter, N. R., Damasceno, A., Khan, N. A., Nilsson, P. M., Alsaid, J., Neupane, D., Kario, K., Beheiry, H., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac130 · Cited by 198
“Partial or complete substitution of salt with potassium chloride is an effective and simple way to reduce salt intake, and thereby BP and cardiovascular event rates.(91) A digital therapeutic strategy designed to facilitate lifestyle modifications, including salt restriction and body weight reduction, successfully red…”
BackgroundInfluentialNovel Insights into Diabetic Kidney Disease
Młynarska, E., Buławska, D., Czarnik, W., Hajdys, J., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., & Franczyk, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810222 · Cited by 167
“According to the ADA and KDIGO guidelines, low sodium diets of 2.3 g/day and 2 g/day, respectively, aim to maintain adequate blood pressure, reduce cardiovascular risk, and reduce albuminuria [67,74,110], while restricted protein intake reduces the progression of CKD [111,112].”
BackgroundInfluentialTen things to know about ten cardiovascular disease risk factors – 2022
Bays, H. E., Agarwala, A., German, C. A., Satish, P., Iluyomade, A., Dudum, R., Thakkar, A., Rifai, M. A., Mehta, A., Thobani, A., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100342 · Cited by 171
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
Self-citationInsights into Salt Handling and Blood Pressure
Ellison, D. H., & Welling, P. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2030212 · Cited by 128
Yuan, Y., Jin, A., Neal, B. C., Feng, X., Qiao, Q., Wang, H., Zhang, R., Li, J., Duan, P., Cao, L., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02286-8 · Cited by 115
Self-citationHypertension Diagnosis, Treatment, and Control in India
Varghese, J. S., Venkateshmurthy, N. S., Sudharsanan, N., Jeemon, P., Patel, S. A., Thirumurthy, H., Roy, A., Tandon, N., Narayan, K. M. V., Prabhakaran, D., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.39098 · Cited by 126
Digital Therapeutics in Hypertension: Evidence and Perspectives
Kario, K., Harada, N., & Okura, A. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19414 · Cited by 109
Implementation of Global Hearts Hypertension Control Programs in 32 Low- and Middle-Income Countries
Moran, A. E., Gupta, R., Pathni, A. K., Osi, K., Dessie, G. A., Zhang, X., Cazabon, D., Banigbe, B., Farrell, M., Erojikwe, O., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.043 · Cited by 93
Self-citationBelardo, D., Michos, E. D., Blankstein, R., Blumenthal, R. S., Ferdinand, K. C., Hall, K., Klatt, K., Natajaran, P., Ostfeld, R. J., Reddy, K., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100323 · Cited by 90
Landscape of cardiometabolic risk factors in Chinese population: a narrative review
Li, J., Liu, H., & Li, S. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01551-3 · Cited by 101
“The effect of salt substitute on CVD prevention was demonstrated by the China Salt Substitute and Stroke Study [71], which presents a cost-effective and scalable approach and may be considered in public health policies.”
BackgroundAdding salt to foods and hazard of premature mortality
Ma, H., Xue, Q., Wang, X., Li, X., Franco, O. H., Li, Y., Heianza, Y., Manson, J. E., & Qi, L. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac208 · Cited by 95
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis
Yin, X., Rodgers, A., Perkovic, A., Huang, L., Li, K.-C., Yu, J., Wu, Y., Wu, J. H. Y., Marklund, M., Huffman, M. D., et al. (2022) · Heart · doi:10.1136/heartjnl-2022-321332 · Cited by 100
Self-citationParati, G., Lackland, D. T., Campbell, N. R. C., Owolabi, M. O., Bavuma, C. M., Beheiry, H., Dzudié, A., Ibrahim, M. M., Aroussy, W. A. E., Singh, S. K., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18884 · Cited by 102
“…sodium during food processing and preparation, use of salt substitutes has been demonstrated to provide a safe and effective approach to prevention of CVD. 52 Another important problem to face in relation to uncontrolled hypertension is the high mortality in child-bearing women due to preeclampsia.”
BackgroundSelf-citationDietary patterns, dietary nutrients and cardiovascular disease
Nestel, P. J., & Mori, T. A. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2301017 · Cited by 107
“A recently published trial conducted in a cohort of 20,995 persons recruited from 600 villages in China confirmed the benefit of substituting 25% of salt intake with a salt substitute [106].”
BackgroundAdvances in the management of chronic kidney disease
Chen, T. K., Hoenig, M. P., Nitsch, D., & Grams, M. E. (2023) · BMJ · doi:10.1136/bmj-2022-074216 · Cited by 122
“72 174 131-135 Whether these interventions also slow CKD progression remains to be determined, as many of these studies were underpowered for this outcome.”
BackgroundAdding Salt to Foods and Risk of Cardiovascular Disease
Ma, H., Wang, X., Li, X., Heianza, Y., & Qi, L. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.09.039 · Cited by 90
Campbell, N. R. C., Whelton, P. K., Orías, M., Wainford, R. D., Cappuccio, F. P., Ide, N., Neal, B. C., Cohn, J., Cobb, L. K., Webster, J. L., et al. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00690-0 · Cited by 90
“● In a recent randomized controlled trial, replacing regular salt with a reduced-sodium salt (where 25% of the sodium was replaced with potassium) in adults with stroke or at high risk for stroke reduced the risk of stroke (14%), cardiovascular events (13%) and premature death (12%) without any evidence of an increase…”
BackgroundSelf-citationKhan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001307 · Cited by 75
“…BP in observational studies, with evidence from a large randomized trial of sodium substitution demonstrating reduced rates of stroke and major cardiovascular events but no significant difference in HF. 92,93 Therefore, reducing dietary sodium intake is likely to have benefit in HF prevention.”
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 107
Global mean potassium intake: a systematic review and Bayesian meta-analysis
Reddin, C., Ferguson, J. P., Murphy, R., Clarke, A., Judge, C. S., Griffith, V., Alvarez‐Iglesias, A., Smyth, A., Mente, A., Yusuf, S., et al. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03128-6 · Cited by 75
“Increasing potassium intake, particularly in populations with low potassium intake and high sodium intake, has emerged to be an important population-level intervention to reduce cardiovascular events, based on the findings from cohort studies and randomised controlled trials, including the recently reported large clus…”
BackgroundInfluentialLu, W. J., Hu, Z., Zhou, X., Qin, Y., Zhang, Y., & Fang, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121456 · Cited by 77
Self-citationEffects of Short-Term Potassium Chloride Supplementation in Patients with CKD
Gritter, M., Wouda, R. D., Yeung, S. M. H., Wieërs, M. L. A. J., Geurts, F., de Ridder, M. A. J., Ramakers, C. R. B., Vogt, L., de Borst, M. H., Rotmans, J. I., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022020147 · Cited by 74
Hypertension in chronic kidney disease—treatment standard 2023
Georgianos, P. I., & Agarwal, R. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad118 · Cited by 116
Brand, A., Visser, M. E., Schoonees, A., & Naude, C. E. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015207 · Cited by 77
Diversity, Equity, and Inclusion in Clinical Research: A Path Toward Precision Health for Everyone
Washington, V., Franklin, J. B., Huang, E. S., Mega, J. L., & Abernethy, A. P. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2804 · Cited by 74
Sodium and Health: Old Myths and a Controversy Based on Denial
Cappuccio, F. P., Campbell, N. R. C., He, F. J., Jacobson, M. F., MacGregor, G. A., Antman, E. M., Appel, L. J., Arcand, J., Blanco‐Metzler, A., Cook, N. R., et al. (2022) · Current Nutrition Reports · doi:10.1007/s13668-021-00383-z · Cited by 66
Potassium homeostasis: sensors, mediators, and targets
McDonough, A. A., & Fenton, R. A. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02718-3 · Cited by 61
“5 mmHg and significantly reduced the rates of stroke and cardiovascular events [82].”
BackgroundAdvances in pathogenesis and treatment of essential hypertension
Ma, J., & Chen, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1003852 · Cited by 99
“One contains only sodium chloride and potassium chloride (51, 52), and the other one contains magnesium sulfate in addition to sodium chloride and potassium chloride (53, 54).”
BackgroundClinical practice guideline for the management of hypertension in China
Chinese Society of Cardiology, C. M. A., Hypertension Committee of Cross-Straits Medicine Exchange Association, & Cardiovascular Disease Prevention and Rehabilitation Committee, C. A. O. R. M. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003431 · Cited by 68
The need for increased pragmatism in cardiovascular clinical trials
Usman, M., Spall, H. G. C. V., Greene, S. J., Pandey, A., McGuire, D. K., Ali, Z. A., Mentz, R. J., Fonarow, G. C., Spertus, J. A., Anker, S. D., et al. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00705-w · Cited by 64
Lichtenstein, A. H., Khera, A., Anderson, C. A. M., Appel, L. J., DeSilva, D. M., Gardner, C. D., Hu, F. B., Jones, D. W., & Petersen, K. S. (2026) · Circulation · doi:10.1161/cir.0000000000001435 · Cited by 82
High-Salt Diet Induces Depletion of Lactic Acid-Producing Bacteria in Murine Gut
Hamad, I., Cardilli, A., Côrte‐Real, B. F., Dyczko, A., Vangronsveld, J., & Kleinewietfeld, M. (2022) · Nutrients · doi:10.3390/nu14061171 · Cited by 62
“High dietary salt intake has been shown to increase the risk to various diseases [13,44,45].”
BackgroundThe modulatory effect of high salt on immune cells and related diseases
Li, X., Alu, A., Wei, Y., Wei, X., & Luo, M. (2022) · Cell Proliferation · doi:10.1111/cpr.13250 · Cited by 56
“It is well recognized that dietary salt intake has a direct causal relationship with blood pressure and can increase the risk of cardiovascular events and death.(166,167,193) Studies have demonstrated that an HSD can contribute to hypertension via the immune system.”
BackgroundThe Burden of Resistant Hypertension Across the World
Brant, L. C. C., Passaglia, L. G., Filho, M. M. P., de Castilho, F. M., Ribeiro, A. L. P., & Nascimento, B. R. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01173-w · Cited by 70
The role of dietary salt in metabolism and energy balance: Insights beyond cardiovascular disease
Wu, Q., Burley, G., Li, L., Lin, S., & Shi, Y. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14980 · Cited by 65
“NaCl, 25% KCl by mass) was associated with lower rates of major cardiovascular events and death compared with a regular salt diet (100% NaCl).(14,124) In an RCT in rural India, hypertensive patients received”
BackgroundGoupil, R., Tsuyuki, R. T., Santesso, N., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A., Campbell, N. R. C., et al. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241770 · Cited by 60
“46 The WHO advises restriction of dietary sodium intake to less than 2 g per day.”
Potassium-Enriched Salt Substitutes: A Review of Recommendations in Clinical Management Guidelines
Xu, X., Zeng, L., Jha, V., Cobb, L. K., Shibuya, K., Appel, L. J., Neal, B. C., & Schutte, A. E. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21343 · Cited by 64
“35 Many of these trials were conducted in regions with notably low dietary potassium consumption, such as rural China 28 and Peru.”
BackgroundInfluentialSelf-citationMosaic theory revised: inflammation and salt play central roles in arterial hypertension
Hengel, F. E., Bénitah, J., & Wenzel, U. O. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00851-8 · Cited by 59
“3 mmHg and decreased risks of stroke, severe cardiovascular events, and overall mortality by ~14%, 13% and 12%, respectively [157].”
BackgroundResultInfluentialPotassium homeostasis – Physiology and pharmacology in a clinical context
Kettritz, R., & Loffing, J. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108489 · Cited by 50
Recommendations for the Use of Dietary Fiber to Improve Blood Pressure Control
Jama, H. A., Snelson, M., Schutte, A. E., Muir, J. G., & Marques, F. Z. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.22575 · Cited by 57
“…trials aimed at increasing long-term fiber intake and reaching the suggested that dietary targets, similar to those aimed at reducing sodium/increasing potassium intake, 61 are needed to confirm levels for future guidelines, as well as calculate cardiovascular benefit according to age and sex.”
BackgroundLi, K., Huang, L., Tian, M., Tanna, G. L. D., Yu, J., Zhang, X., Yin, X., Liu, Y., Hao, Z., Zhou, B., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.059573 · Cited by 49
Self-citationLifestyle management to prevent atherosclerotic cardiovascular disease: evidence and challenges
Trier, T. J. V., Mohammadnia, N., Snaterse, M., Peters, R. J. G., Jorstad, H. T., & Bax, W. A. (2021) · Netherlands Heart Journal · doi:10.1007/s12471-021-01642-y · Cited by 62
“5g) based on meta-analyses that found strong evidence supporting a linear dose–response relationship between reduction of sodium intake and blood pressure [29] and a study showing that a switch from regular (sodium-containing) salt to potassiumenriched salt resulted in a significant reduction of cardiovascular events…”
BackgroundHypotension as a marker or mediator of perioperative organ injury: a narrative review
Ackland, G. L., & Abbott, T. E. F. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.01.012 · Cited by 56
Immunomodulation and immunopharmacology in heart failure
Markousis‐Mavrogenis, G., Baumhove, L., Al‐Mubarak, A. A., Aboumsallem, J. P., Bömer, N., Voors, A. A., & van der Meer, P. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00919-6 · Cited by 52
“This intervention reduced the risk of adverse cardiovascular events compared with participants assigned to regular salt (100% NaCl), particularly in women 377 .”
Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
Kario, K., Chia, Y. C., Siddique, S., Turana, Y., Li, Y., Chen, C., Nailes, J. M., Minh, H. V., Buranakitjaroen, P., Cheng, H., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14440 · Cited by 51
Self-citationHigher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors
Wang, Z., Fan, Z., Yang, L., Liu, L., Sheng, C., Song, F., Huang, Y., & Chen, K. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1014400 · Cited by 57
“This huge difference is similar to the results of previous studies (13, 38, 39).”
ResultIncreasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias
Jøns, C., Zheng, C., Winsløw, U., Danielsen, E. M., Sakthivel, T., Frandsen, E. A., Saffi, H., Vakilzadeh-Hashemi, S. S., Haugan, K., Bruun, N. E., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2509542 · Cited by 61
Navar, A. M., Fine, L. J., Ambrosius, W. T., Brown, A., Douglas, P. S., Johnson, K., Khera, A. V., Lloyd-Jones, D., Michos, E. D., Mujahid, M., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100430 · Cited by 43
“Large polypill trials, such as TIPS-3 with CVD events as a primary outcome in older adults, have been conducted outside of the United States, but larger polypill studies in broader clinical settings in the United States have not been conducted.”
BackgroundInfluentialAliasgharzadeh, S., Tabrizi, J. S., Nikniaz, L., Ebrahimi‐Mameghani, M., & Yagin, N. L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277929 · Cited by 57
“The duration of the studies ranged from two weeks [22, 52] to five years [33].”
BackgroundOjji, D. B., Salam, A., Sani, M. U., Ogah, O. S., Schutte, A. E., Huffman, M. D., Pant, R., Ghosh, A., Dhurjati, R., Lakshmi, J. K., et al. (2024) · JAMA · doi:10.1001/jama.2024.18080 · Cited by 55
Mullen, M. T., & Anderson, C. S. (2022) · Stroke · doi:10.1161/strokeaha.121.036885 · Cited by 46
Tan, M., He, F. J., Morris, J. K., & MacGregor, G. A. (2022) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2021-000408 · Cited by 44
Deng, P., Fu, Y., Chen, M.-S., Wang, D., & Si, L. (2023) · International Journal for Equity in Health · doi:10.1186/s12939-023-01988-2 · Cited by 38
“One open-label, cluster-randomized trial (Salt Substitute and Stroke Study, SSaSS) demonstrated that salt substitution could lower the risk of cardiovascular events [46], and a modeling study in China projected that 461,000 cardiovascular deaths and 743,000 nonfatal cardiovascular events could be avoided each year by…”
BackgroundGrimm, P. R., Tatomir, A., Rosenbæk, L. L., Kim, B. Y., Li, D., Delpire, E. J., Fenton, R. A., & Welling, P. A. (2023) · Journal of Clinical Investigation · doi:10.1172/jci158498 · Cited by 44
“Recent clinical trials indicate that modest substitutions of dietary potassium for sodium can lower BP, benefit cardiovascular health, and reduce mortality in populations consuming high-sodium, low-potassium foods (7, 69).”
BackgroundPotassium Intake and Human Health
D’Elia, L. (2024) · Nutrients · doi:10.3390/nu16060833 · Cited by 48
“…chloride and 25% potassium chloride) in place of sodium chloride salt (100% sodium chloride), also associated with a reduction in cardiovascular events in large populations [28], or the use of potassium supplementation with slow-release potassium salts, which are generally safe at a low dose [29].”
BackgroundManagement of traditional risk factors for the development and progression of chronic kidney disease
Lo, R. H., Narasaki, Y., Lei, S., & Rhee, C. M. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad101 · Cited by 45
“Of note, a recent clinical trial comparing the use of salt substitutes (25% potassium chloride) compared to regular salt (100% sodium chloride) found decreased rates of stroke,major adverse cardiovascular events, and death [28].”
BackgroundMcCarthy, C. P., Bruno, R. M., Rahimi, K., Touyz, R. M., & McEvoy, J. W. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.24173 · Cited by 56
Maniero, C., Lopuszko, A., Papalois, K.-B., Gupta, A. K., Kapil, V., & Khanji, M. Y. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac163 · Cited by 54
O’Hearn, M., Erndt-Marino, J. D., Gerber, S., Lauren, B. N., Economos, C. D., Wong, J. B., Blumberg, J. B., & Mozaffarian, D. (2022) · Nature Communications · doi:10.1038/s41467-022-34195-8 · Cited by 48
Effect of low sodium and high potassium diet on lowering blood pressure and cardiovascular events
Kim, B. S., Yu, M., & Shin, J. (2024) · Clinical Hypertension · doi:10.1186/s40885-023-00259-0 · Cited by 63
“In a SSaSS trial [116], the group that replaced regular salt with a salt-substitute consisting of 75% sodium chloride and 25% potassium chloride showed a reduced risk of major adverse cardiovascular events (risk ratio 0.87), death from any cause (risk ratio 0.88), death from vascular insult (risk…”
BackgroundInfluentialWang, Y., Wang, J., Chen, S., Li, B., Lu, X., & Li, J. (2023) · Stroke · doi:10.1161/strokeaha.122.040848 · Cited by 37
Dietary salt intake in Japan - past, present, and future
Tsuchihashi, T. (2022) · Hypertension Research · doi:10.1038/s41440-022-00888-2 · Cited by 43
“In China, the average sodium intake was reported to be 5013 mg/day (equivalent to 12.7 g of salt), and 92.6% of adults’ sodium intake exceeded the standard in the Chinese proposed intake for preventing noncommunicable chronic diseases (PI-NCD) [47].”
InfluentialSang, J., Dhakal, S., Shrestha, B., Nath, D. K., Kim, Y., Ganguly, A., Montell, C., & Lee, Y. (2023) · eLife · doi:10.7554/elife.93464 · Cited by 40
“…excessive salt can contribute to various health issues in mammals, including hypertension, osteoporosis, gastrointestinal cancer, autoimmune diseases, and can lead to death ( Heaney, 2006 ; Jones et al., 1997 ; Luft et al., 1979 ; Sharif et al., 2018 ; Strazzullo et al., 2009 ; Neal et al., 2021 ).”
Greenwood, H., Barnes, K. A., Clark, J. M., Ball, L., & Albarqouni, L. (2024) · Annals of Internal Medicine · doi:10.7326/m23-2626 · Cited by 39
“Three RCTs (23215 participants) reported the effect on MACE (15, 31, 32).”
BackgroundMethodInfluentialA systematic review of diet and medication use among centenarians and near-centenarians worldwide
Dai, Z., Lee, S. Y., Sharma, S., Ullah, S., Tan, E. C. K., Brodaty, H., Schutte, A. E., & Sachdev, P. S. (2024) · GeroScience · doi:10.1007/s11357-024-01247-4 · Cited by 42
“…multiple studies in the general older populations have demonstrated that high salt diets increased the risks of cognitive decline or dementia [57] and mortality [58, 59] while replacing pure salt with potassium-enriched salt substitute reduced the incidence of cardiovascular events and deaths [60].”
BackgroundInterventions That Successfully Reduced Adults Salt Intake—A Systematic Review
Silva-Santos, T., Moreira, P. A. M., Rodrigues, M., Padrão, P., Pinho, O., Norton, P. M. P. N. S., Ndrio, A., & Gonçalves, C. (2021) · Nutrients · doi:10.3390/nu14010006 · Cited by 45
“Also, a recent study showed that the use of salt substitute (with potassium in the constitution) decreased urinary sodium excretion and the rates of stroke, cardiovascular events, and deaths from any cause in people over 60 years of age [44].”
BackgroundNiu, Z., Duan, Z., Wei, J., Wang, F., Han, D., Zhang, K., Jing, Y., Wen, W., Qin, W., & Yang, X. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113901 · Cited by 41
Self-citationDhungana, R. R., Pedišić, Ž., & de Courten, M. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01884-8 · Cited by 48
“34 mmHg but also reduced the risk of stroke and cardiovascular morbidity and mortality during the five-year follow-up [91].”
Background
Metadata
- Authors
- Neal, B., Wu, Y., Feng, X., Zhang, R., Zhang, Y., Shi, J., Zhang, J., Tian, M., Huang, L., Li, Z., Yu, Y., Zhao, Y., Zhou, B., Sun, J., Liu, Y., Yin, X., Hao, Z., Yu, J., Li, K.-C., Zhang, X., Duan, P., Wang, F., Ma, B., Shi, W., Di Tanna, G. L., Stepien, S., Shan, S., Pearson, S.-A., Li, N., Yan, L. L., Labarthe, D., & Elliott, P.
- Affiliations
- The George Institute for Global Health (GB)
- Harbin Medical University (CN)
- From the George Institute for Global Health (B.N., M.T., L.H., Y.L., X.Y., J.Y., K.-C.L., G.L.D.T., S. Stepien, S. Shan) and the Centre for Big Data Research in Health (S.-A.P.), University of New South Wales, and George Clinical (N.L.) — all in Sydney; the School of Public Health (B.N., K.-C.L., P.E.), the U.K. Dementia Research Institute (P.E.), the British Heart Foundation Centre for Research Excellence (P.E.), and the NIHR Imperial Biomedical Research Centre (P.E.), Imperial College London, Health Data Research (P.E.), the NIHR Health Protection Research Unit in Chemical and Radiation Threats and Hazards (P.E.), and the Medical Research Council Centre for Environment and Health (P.E.) — all in London; Peking University Clinical Research Center, Peking University (Y.W.), the George Institute for Global Health at Peking University Health Science Center (Y.W., M.T., Z.H., X.Z., L.L.Y.), and the Department of Cardiology, Peking University Third Hospital (J.Y.), Beijing, the School of Public Health, Changzh...
- Northwestern University (US)
- ORCID
- Neal, Bruce
- Wu, Yangfeng
- Zhang, Ruijuan
- Zhang, Yuhong
- Shi, Jingpu
- Zhang, Jianxin
- Tian, Maoyi
- Huang, Liping
- Li, Zhifang
- Yu, Yan
- Zhao, Yi
- Zhou, Bo
- Liu, Yishu
- Yin, Xuejun
- Yu, Jie
- Zhang, Xinyi
- Duan, Peifen
- Wang, Faxuan
- Ma, Bing
- Shi, Weiwei
- Stepien, Sandrine
- Shan, Sana
- Pearson, Sallie-Anne
- Li, Nicole
- Yan, Lijing L.
- Labarthe, Darwin
- Elliott, Paul
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-16
- Volume
- 385
- Issue
- 12
- Pages
- 1067-1077
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198627281
- Cited by
- 742
- References
- 21
- Citations by year
- 2026: 119 · 2025: 165 · 2024: 131 · 2023: 168 · 2022: 133 · 2021: 24
- FWCI
- 72.81
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Health and Medical Research Council (APP1049417, APP1164206)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- salt substitutes, potassium chloride, sodium chloride, hypertension, stroke prevention, major adverse cardiovascular events, mortality, hyperkalemia, blood pressure, older adults, rural China, dietary salt reduction, secondary stroke prevention, cost-effectiveness
- MeSH terms
- Aged, Cardiovascular Diseases, China, Diet, Sodium-Restricted, Female, Humans, Hyperkalemia, Hypertension, Male, Middle Aged, Mortality, Potassium, Dietary, Stroke, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.